HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Aug. 9, 2022 (HealthDay News) -- Medical cannabis use may be common in midlife individuals experiencing menopause-related symptoms, according to a study published online Aug. 2 in Menopause.
M. Kathryn Dahlgren, Ph.D., from the McLean Hospital Imaging Center in Belmont, Massachusetts, and colleagues assessed patterns of medical cannabis use in 131 perimenopausal and 127 postmenopausal individuals. Participants were recruited through online postings on social media platforms and via Rally, the Mass General Brigham online recruitment platform.
The researchers found that most participants reported current cannabis use (86.1 percent) and endorsed using medical cannabis for menopause-related symptoms (78.7 percent), including sleep disturbance (67.4 percent) and mood/anxiety (46.1 percent). Smoking (84.3 percent) and edibles (78.3 percent) were the most common modes of use. Perimenopausal participants reported increased use of medical cannabis to treat menopause-related mood/anxiety symptoms compared with postmenopausal participants.
"Given the lack of clinical trial data on the efficacy and safety of medical cannabis for management of menopause symptoms, more research is needed before this treatment can be recommended in clinical practice," Stephanie Faubion, M.D., medical director of the North American Menopause Society, said in a statement. "Health care professionals should query their patients about the use of medical cannabis for menopause symptoms and provide evidence-based recommendations for symptom management."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on September 21, 2022